Lota S. Zoth - May 13, 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role
Director
Signature
/s/ Lota Zoth
Stock symbol
INO
Transactions as of
May 13, 2022
Transactions value $
-$7,128
Form type
4
Date filed
5/17/2022, 04:28 PM
Previous filing
May 9, 2022
Next filing
May 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +18K +71.95% 43K May 13, 2022 Direct F1
transaction INO Common Stock Sale -$7.13K -3.6K -8.37% $1.98 39.4K May 16, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -18K -100% $0.00* 0 May 13, 2022 Common Stock 18K Direct F1
transaction INO Restricted Stock Unit Award $0 +19K $0.00 19K May 16, 2022 Common Stock 19K Direct F3, F4
transaction INO Common Stock Options Award $0 +28K $0.00 28K May 16, 2022 Common Stock 28K $1.89 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 13, 2022.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 16, 2023.
F4 This grant was made pursuant to the issuer's non-employee director compensation policy.
F5 Options to vest 100% on May 16, 2023.